Abstract B58: Combination therapy with the novel small molecule drug conjugate SW V-49 and gemcitabine is a potent pancreatic cancer therapeutic

Author(s):  
Kerri A. Ohman ◽  
Timothy M. Nywening ◽  
Suwanna Vangveravong ◽  
Dirk Spitzer ◽  
William G. Hawkins
2014 ◽  
Vol 8 (5) ◽  
pp. 956-967 ◽  
Author(s):  
Yassar M. Hashim ◽  
Dirk Spitzer ◽  
Suwanna Vangveravong ◽  
Mary C. Hornick ◽  
Gunjal Garg ◽  
...  

2016 ◽  
Vol 34 (15_suppl) ◽  
pp. 2586-2586
Author(s):  
Michael J. Morris ◽  
Daniel Peter Petrylak ◽  
A. Oliver Sartor ◽  
Nicholas J. Vogelzang ◽  
Michael Groaning ◽  
...  

MedChemComm ◽  
2019 ◽  
Vol 10 (12) ◽  
pp. 2170-2174 ◽  
Author(s):  
Andrew Michael Beekman ◽  
Marco M. D. Cominetti ◽  
Oliver Charles Cartwright ◽  
Dale L. Boger ◽  
Mark Searcey

A SMDC is delivered to GCPII, an important cancer target. The payload is released by enzymes overexpressed in cancer cell lines. The SMDC relies on GCPII expression for efficacy.


2021 ◽  
Vol 64 (7) ◽  
pp. 4117-4129
Author(s):  
Francesca Gallo ◽  
Barbara Korsak ◽  
Christoph Müller ◽  
Torsten Hechler ◽  
Desislava Yanakieva ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document